The IDEAL trial - a study protocol for a phase III randomized, double-blinded clinical trial assessing the ultra-short antibiotic prophylaxis of Isoniazid and Rifapentine in non-immunosuppressed patients with newly diagnosed latent tuberculosis. PPCR [Internet]. 2020 May 21 [cited 2024 Nov. 23];6(1):9-14. Available from: https://journal.ppcr.org/index.php/ppcrjournal/article/view/96